These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats. Sun X, Ma S, Zang YM, Lu SY, Guo HT, Bi H, Wang YM, Ma H, Ma XL, Pei JM. Life Sci; 2006 Apr 18; 78(21):2516-22. PubMed ID: 16336977 [Abstract] [Full Text] [Related]
24. Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist. Rong F, Peng Z, Ye MX, Zhang QY, Zhao Y, Zhang SM, Guo HT, Hui B, Wang YM, Liang C, Gu CH, Tao C, Cui Q, Yu SQ, Yi DH, Pei JM. Arch Med Res; 2009 May 18; 40(4):227-34. PubMed ID: 19608010 [Abstract] [Full Text] [Related]
25. Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension. Wu Q, Wang HY, Li J, Zhou P, Wang QL, Zhao L, Fan R, Wang YM, Xu XZ, Yi DH, Yu SQ, Pei JM. PLoS One; 2013 May 18; 8(5):e60850. PubMed ID: 23667430 [Abstract] [Full Text] [Related]
26. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis. Yin W, Zhang P, Huang JH, Zhang QY, Fan R, Li J, Zhou JJ, Hu YZ, Guo HT, Zhang SM, Wang YM, Kaye AD, Gu CH, Liu JC, Cheng L, Cui Q, Yi DH, Pei JM. Eur J Pharmacol; 2009 Apr 01; 607(1-3):135-42. PubMed ID: 19233160 [Abstract] [Full Text] [Related]
27. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes. Zhou JJ, Bian JS, Pei JM, Wu S, Li HY, Wong TM. Br J Pharmacol; 2002 Apr 01; 135(7):1675-84. PubMed ID: 11934807 [Abstract] [Full Text] [Related]
28. Anti-arrhythmic effects of kappa-opioid receptor and its changes in ischemia and reperfusion. Jin-Cheng L, Wen Y, Zhao Y, Quan-Yu Z, Shu-Miao Z, Hai-Tao G, Hui B, Yue-Min W, Xin S, Liang C, Qin C, Shi-Qiang Y, Kaye AD, Ding-Hua Y, Jian-Ming P. Arch Med Res; 2008 Jul 01; 39(5):483-8. PubMed ID: 18514092 [Abstract] [Full Text] [Related]
29. Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats. Zhou X, Wang D, Zhang Y, Zhang J, Xiang D, Wang H. BMC Endocr Disord; 2015 Feb 28; 15():7. PubMed ID: 25887435 [Abstract] [Full Text] [Related]
30. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase. Lv L, Jiang SS, Xu J, Gong JB, Cheng Y. Clin Exp Pharmacol Physiol; 2012 Jan 28; 39(1):20-7. PubMed ID: 22004361 [Abstract] [Full Text] [Related]
31. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig. Wang YJ, Rasakham K, Huang P, Chudnovskaya D, Cowan A, Liu-Chen LY. J Pharmacol Exp Ther; 2011 Nov 28; 339(2):438-50. PubMed ID: 21841040 [Abstract] [Full Text] [Related]
32. Role of κ-opioid receptor in hypoxic pulmonary artery hypertension and its underlying mechanism. Zhang L, Li J, Shi Q, Fan R, Kaye AJ, Wang Y, Sun X, Rivera FB, Kaye AD, Pei J. Am J Ther; 2013 Nov 28; 20(4):329-36. PubMed ID: 23838631 [Abstract] [Full Text] [Related]
33. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation. Li JG, Zhang F, Jin XL, Liu-Chen LY. J Pharmacol Exp Ther; 2003 May 28; 305(2):531-40. PubMed ID: 12606694 [Abstract] [Full Text] [Related]
34. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization. Chen C, Chiu YT, Wu W, Huang P, Mann A, Schulz S, Liu-Chen LY. Biochem J; 2016 Feb 15; 473(4):497-508. PubMed ID: 26635353 [Abstract] [Full Text] [Related]
35. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Wu S, Li HY, Wong TM. Circ Res; 1999 Jun 25; 84(12):1388-95. PubMed ID: 10381890 [Abstract] [Full Text] [Related]
36. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes. Wang G, Wang H, Yang Y, Wong TM. Eur J Pharmacol; 2004 Sep 13; 498(1-3):53-8. PubMed ID: 15363975 [Abstract] [Full Text] [Related]
37. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells. Li J, Li JG, Chen C, Zhang F, Liu-Chen LY. Mol Pharmacol; 2002 Jan 13; 61(1):73-84. PubMed ID: 11752208 [Abstract] [Full Text] [Related]
38. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B). Wu G, Wang H, Yang J, Yang Y, Liu C, Jing L, Wong TM. Eur J Pharmacol; 2008 Oct 24; 595(1-3):52-7. PubMed ID: 18721804 [Abstract] [Full Text] [Related]
39. Phospholipase C inhibitors attenuate arrhythmias induced by kappa-receptor stimulation in the isolated rat heart. Bian JS, Zhang WM, Xia Q, Wong TM. J Mol Cell Cardiol; 1998 Oct 24; 30(10):2103-10. PubMed ID: 9799662 [Abstract] [Full Text] [Related]
40. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation. Zhang F, Li J, Li JG, Liu-Chen LY. J Pharmacol Exp Ther; 2002 Sep 24; 302(3):1184-92. PubMed ID: 12183679 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]